Works by Pinilla‐Ibarz, Javier

Results: 78

Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: Results from a pilot randomized trial.

Published in:

2020

By:

Jim, Heather S. L.;
Hyland, Kelly A.;
Nelson, Ashley M.;
Pinilla‐Ibarz, Javier;
Sweet, Kendra;
Gielissen, Marieke;
Bulls, Hailey;
Hoogland, Aasha I.;
Jacobsen, Paul B.;
Knoop, Hans;
Pinilla-Ibarz, Javier

Publication type:

journal article

Correction: Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee.

Published in:

2022

By:

Januzzi, James L.;
Garasic, Joseph M.;
Kasner, Scott E.;
McDonald, Vickie;
Petrie, Mark C.;
Seltzer, Jonathan;
Mauro, Michael;
Croce, Kevin;
Berman, Ellin;
Deininger, Michael;
Hochhaus, Andreas;
Pinilla-Ibarz, Javier;
Nicolini, Franck;
Kim, Dong-Wook;
DeAngelo, Daniel J.;
Kantarjian, Hagop;
Xu, Jing;
Hall, Tracey;
Srivastava, Shouryadeep;
Naranjo, Daniel

Publication type:

Correction Notice

Correction: Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee.

Published in:

2022

By:

Januzzi, James L.;
Garasic, Joseph M.;
Kasner, Scott E.;
McDonald, Vickie;
Petrie, Mark C.;
Seltzer, Jonathan;
Mauro, Michael;
Croce, Kevin;
Berman, Ellin;
Deininger, Michael;
Hochhaus, Andreas;
Pinilla-Ibarz, Javier;
Nicolini, Franck;
Kim, Dong-Wook;
DeAngelo, Daniel J.;
Kantarjian, Hagop;
Xu, Jing;
Hall, Tracey;
Srivastava, Shouryadeep;
Naranjo, Daniel

Publication type:

Correction Notice

Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee.

Published in:

Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-021-01221-z

By:

Januzzi, James L.;
Garasic, Joseph M.;
Kasner, Scott E.;
McDonald, Vickie;
Petrie, Mark C.;
Seltzer, Jonathan;
Mauro, Michael;
Croce, Kevin;
Berman, Ellin;
Deininger, Michael;
Hochhaus, Andreas;
Pinilla-Ibarz, Javier;
Nicolini, Franck;
Kim, Dong-Wook;
DeAngelo, Daniel J.;
Kantarjian, Hagop;
Xu, Jing;
Hall, Tracey;
Srivastava, Shouryadeep;
Naranjo, Daniel

Publication type:

Article

Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee.

Published in:

Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-021-01221-z

By:

Januzzi, James L.;
Garasic, Joseph M.;
Kasner, Scott E.;
McDonald, Vickie;
Petrie, Mark C.;
Seltzer, Jonathan;
Mauro, Michael;
Croce, Kevin;
Berman, Ellin;
Deininger, Michael;
Hochhaus, Andreas;
Pinilla-Ibarz, Javier;
Nicolini, Franck;
Kim, Dong-Wook;
DeAngelo, Daniel J.;
Kantarjian, Hagop;
Xu, Jing;
Hall, Tracey;
Srivastava, Shouryadeep;
Naranjo, Daniel

Publication type:

Article

Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison.

Published in:

Supportive Care in Cancer, 2013, v. 21, n. 4, p. 1097, doi. 10.1007/s00520-012-1630-5

By:

Phillips, Kristin;
Pinilla-Ibarz, Javier;
Sotomayor, Eduardo;
Lee, Morgan;
Jim, Heather;
Small, Brent;
Sokol, Lubomir;
Lancet, Jeffrey;
Tinsley, Sara;
Sweet, Kendra;
Komrokji, Rami;
Jacobsen, Paul

Publication type:

Article

Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.943354

By:

Maharaj, Kamira;
Uriepero, Angimar;
Sahakian, Eva;
Pinilla-Ibarz, Javier

Publication type:

Article

Frontline treatment approaches in TP53-aberrant mantle cell lymphoma.

Published in:

Leukemia & Lymphoma, 2023, v. 64, n. 1, p. 230, doi. 10.1080/10428194.2022.2131407

By:

Shah, Nikesh N.;
Castillo-Tokumori, Franco;
Whiting, Junmin;
Boulware, David;
Sandoval-Sus, Jose;
Knepper, Todd C.;
Hussaini, Mohammad;
Tao, Jianguo;
Chavez, Julio C.;
Isenalumhe, Leidy;
Gaballa, Sameh;
Saeed, Hayder;
Bello, Celeste;
Sokol, Lubomir;
Pinilla-Ibarz, Javier;
Shah, Bijal D.

Publication type:

Article

Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center.

Published in:

Leukemia & Lymphoma, 2022, v. 63, n. 1, p. 109, doi. 10.1080/10428194.2021.1971218

By:

Zhang, Yumeng;
Seminario-Vidal, Lucia;
Varnadoe, Christa;
Lu, Yuanyuan;
Dong, Ning;
Salamanca, Christopher;
Whiddon, Shannen;
Bennett, Janice;
Hargis, Rebecca;
Liu, Hien;
Montejo, Michael;
Hussaini, Mohammad;
Harro, Carly;
Messina, Jane;
Benson, Kaaron;
Pinilla-Ibarz, Javier;
Conejo-Garcia, Jose;
Sokol, Lubomir

Publication type:

Article

Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.

Published in:

Leukemia & Lymphoma, 2018, v. 59, n. 1, p. 59, doi. 10.1080/10428194.2017.1323271

By:

Sandoval-Sus, Jose D.;
Chavez, Julio C.;
Dalia, Samir;
Naqvi, Syeda Mahrukh Hussnain;
Talati, Chetasi;
Nodzon, Lisa;
Kharfan-Dabaja, Mohamed A.;
Pinilla-Ibarz, Javier

Publication type:

Article

EBV-positive Richter’s syndrome with laboratory features of Burkitt’s lymphoma, in Ibrutinib-treated chronic lymphocytic leukemia.

Published in:

2017

By:

Hussaini, Mohammad O.;
Rehman, Alman;
Chavez, Julio C.;
Pinilla-Ibarz, Javier;
Horna, Pedro

Publication type:

Case Study

Transformation to Hodgkin lymphoma in chronic lymphocytic leukemia coexisting with Epstein-Barr viremia.

Published in:

2014

By:

Dalia, Samir;
Brayer, Jason;
Horna, Pedro;
Zhang, Hailing;
Pinilla-Ibarz, Javier

Publication type:

Case Study

A Close Association of Autoimmune-Mediated Processes and Autoimmune Disorders with Chronic Myelomonocytic Leukemia: Observation from a Single Institution.

Published in:

Acta Haematologica, 2015, v. 133, n. 2, p. 249, doi. 10.1159/000365877

By:

Peker, Deniz;
Padron, Eric;
Bennett, John M.;
Zhang, Xiaohui;
Horna, Pedro;
Epling-Burnette, Pearlie K.;
Lancet, Jeffrey E.;
Pinilla-Ibarz, Javier;
Moscinski, Lynn;
List, alan F.;
Komrokji, Rami S.;
Zhang, Ling

Publication type:

Article

Correlates of fatigue severity in patients with chronic myeloid leukemia treated with targeted therapy.

Published in:

2022

By:

Oswald, Laura B.;
Hyland, Kelly A.;
Eisel, Sarah L.;
Hoogland, Aasha I.;
Knoop, Hans;
Nelson, Ashley M.;
Pinilla-Ibarz, Javier;
Sweet, Kendra;
Jacobsen, Paul B.;
Jim, Heather S. L.

Publication type:

journal article

Ponatinib after failure of second‐generation tyrosine kinase inhibitor in resistant chronic‐phase chronic myeloid leukemia.

Published in:

American Journal of Hematology, 2022, v. 97, n. 11, p. 1419, doi. 10.1002/ajh.26686

By:

Kantarjian, Hagop M.;
Jabbour, Elias;
Deininger, Michael;
Abruzzese, Elisabetta;
Apperley, Jane;
Cortes, Jorge;
Chuah, Charles;
DeAngelo, Daniel J.;
DiPersio, John;
Hochhaus, Andreas;
Lipton, Jeffrey;
Nicolini, Franck E.;
Pinilla‐Ibarz, Javier;
Rea, Delphine;
Rosti, Gianantonio;
Rousselot, Philippe;
Shah, Neil P.;
Talpaz, Moshe;
Srivastava, Shouryadeep;
Ren, Xiaowei

Publication type:

Article

Autoimmune diseases and myelodysplastic syndromes.

Published in:

American Journal of Hematology, 2016, v. 91, n. 5, p. E280, doi. 10.1002/ajh.24333

By:

Komrokji, Rami S.;
Kulasekararaj, Austin;
Al Ali, Najla H.;
Kordasti, Shahram;
Bart-Smith, Emily;
Craig, Benjamin M.;
Padron, Eric;
Zhang, Ling;
Lancet, Jeffrey E.;
Pinilla-Ibarz, Javier;
List, Alan F.;
Mufti, Ghulam J.;
Epling-Burnette, Pearlie K.

Publication type:

Article

WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides.

Published in:

American Journal of Hematology, 2015, v. 90, n. 7, p. 602, doi. 10.1002/ajh.24014

By:

Brayer, Jason;
Lancet, Jeffrey E.;
Powers, John;
List, Alan;
Balducci, Lodovico;
Komrokji, Rami;
Pinilla-Ibarz, Javier

Publication type:

Article

Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.

Published in:

American Journal of Hematology, 2013, v. 88, n. 7, p. 566, doi. 10.1002/ajh.23454

By:

Mishra, Asmita;
Corrales-Yepez, Maria;
Ali, Najla Al;
Kharfan-Dabaja, Mohamed;
Padron, Eric;
Zhang, Ling;
Epling-Burnette, Pearlie K.;
Pinilla-Ibarz, Javier;
Lancet, Jeffrey E.;
List, Alan F.;
Komrokji, Rami S.

Publication type:

Article

Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes.

Published in:

American Journal of Hematology, 2012, v. 87, n. 11, p. 1006, doi. 10.1002/ajh.23303

By:

Komrokji, Rami S.;
Corrales-Yepez, Maria;
Kharfan-Dabaja, Mohamed A.;
Al Ali, Najla H.;
Padron, Eric;
Rollison, Dana E.;
Pinilla-Ibarz, Javier;
Zhang, Ling;
Epling-Burnette, Pearlie K.;
Lancet, Jeffrey E.;
List, Alan F.

Publication type:

Article

HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model.

Published in:

Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.590072

By:

Maharaj, Kamira;
Powers, John J.;
Mediavilla-Varela, Melanie;
Achille, Alex;
Gamal, Wael;
Quayle, Steven;
Jones, Simon S.;
Sahakian, Eva;
Pinilla-Ibarz, Javier

Publication type:

Article

Role of ofatumumab in treatment of chronic lymphocytic leukemia.

Published in:

Journal of Blood Medicine, 2011, v. 2, p. 71, doi. 10.2147/JBM.S13063

By:

Veliz, Marays;
Pinilla-Ibarz, Javier

Publication type:

Article

Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 382, doi. 10.1016/j.clml.2024.02.001

By:

Chavez, Julio C;
Grajales, Ariel;
Sandoval-Sus, Jose;
Turba, Elyce;
Nodzon, Lisa;
Uriepero-Palma, Angimar;
Ammad-Ud-Din, Mohammad;
Sahakian, Eva;
Komrokji, Rami;
Sokol, Lubomir;
Locke, Frederick L;
Shah, Bijal;
Lancet, Jeffrey;
Sotomayor, Eduardo M;
Kharfan-Dabaja, Mohamed A.;
Bello, Celeste;
Pinilla-Ibarz, Javier

Publication type:

Article

CLL-115: First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S318, doi. 10.1016/S2152-2650(21)01750-X

By:

Byrd, John C.;
Hillmen, Peter;
Ghia, Paolo;
Kater, Arnon P.;
Chanan-Khan, Asher;
Furman, Richard R.;
O'Brien, Susan;
Yenerel, Mustafa Nuri;
Illes, Arpad;
Kay, Neil;
Garcia-Marco, Jose A.;
Mato, Anthony;
Pinilla-Ibarz, Javier;
Seymour, John F.;
Lepretre, Stephane;
Stilgenbauer, Stephan;
Robak, Tadeusz;
Patel, Priti;
Higgins, Kara;
Sohoni, Sophia

Publication type:

Article

Poster: CLL-115: First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S220, doi. 10.1016/S2152-2650(21)01389-6

By:

Byrd, John C.;
Hillmen, Peter;
Ghia, Paolo;
Kater, Arnon P.;
Chanan-Khan, Asher;
Furman, Richard R.;
O'Brien, Susan;
Yenerel, Mustafa Nuri;
Illes, Arpad;
Kay, Neil;
Garcia-Marco, Jose A.;
Mato, Anthony;
Pinilla-Ibarz, Javier;
Seymour, John F.;
Lepretre, Stephane;
Stilgenbauer, Stephan;
Robak, Tadeusz;
Patel, Priti;
Higgins, Kara;
Sohoni, Sophia

Publication type:

Article

Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective, Single-Institution Analysis.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S284, doi. 10.1016/j.clml.2019.07.224

By:

Rose, Ashley;
Kerr, Daniel;
Kristen, Gonter-Aubin;
Thanh, Afiat;
Julio, Chavez;
Javier, Pinilla-Ibarz

Publication type:

Article

A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes.

Published in:

2019

By:

Komrokji, Rami S.;
Wei, Sheng;
Mailloux, Adam W.;
Zhang, Ling;
Padron, Eric;
Sallman, David;
Lancet, Jeffrey E.;
Tinsley, Sara;
Nardelli, Lisa A.;
Pinilla-Ibarz, Javier;
Epling-Burnette, Pearlie K.;
List, Alan F.

Publication type:

journal article

Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center Experience.

Published in:

2018

By:

Kharfan-Dabaja, Mohamed A.;
Kumar, Ambuj;
Stingo, Facundo E.;
Khimani, Farhad;
Hussaini, Mohammad;
Ayala, Ernesto;
Nishihori, Taiga;
Shah, Bijal;
Locke, Frederick L.;
Pinilla-Ibarz, Javier;
Chavez, Julio C.

Publication type:

journal article

A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia.

Published in:

2017

By:

Mirza, Abu-Sayeef;
Lancet, Jeffrey E.;
Sweet, Kendra;
Padron, Eric;
Pinilla-Ibarz, Javier;
Nardelli, Lisa;
Cubitt, Christopher;
List, Alan F.;
Komrokji, Rami S.

Publication type:

journal article

5-Year Updates from the Pivotal Phase 2 Ponatinib PACE Trial: Efficacy, Safety and Landmark Analysis in Heavily Pretreated Patients with Chronic-Phase Chronic Myeloid Leukemia.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S307, doi. 10.1016/j.clml.2017.07.105

By:

Cortes, Jorge E.;
Kantarjian, Hagop M.;
Pinilla-Ibarz, Javier;
le Coutre, Philipp D.;
Paquette, Ronald;
Chuah, Charles;
Nicolini, Franck E.;
Talpaz, Moshe;
Baccarani, Michele;
Deininger, Michael W.;
Hochhaus, Andreas;
Hughes, Timothy P.;
Shah, Neil P.;
Lustgarten, Stephanie;
Santillana, Sergio;
Rivera, Victor M.;
Clackson, Tim;
Mueller, Martin C.

Publication type:

Article

Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management.

Published in:

2017

By:

Cortes, Jorge E.;
Jimenez, Carlos A.;
Mauro, Michael J.;
Geyer, Alex;
Pinilla-Ibarz, Javier;
Smith, B. Douglas

Publication type:

journal article

4-Year Results from the Pivotal Phase 2 PACE Trial: Efficacy and Safety in Heavily Pretreated Leukemia Patients.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S56, doi. 10.1016/j.clml.2016.07.082

By:

Cortes, Jorge;
Pinilla-Ibarz, Javier;
le Coutre, Philipp;
Paquette, Ronald;
Chuah, Charles;
Nicolini, Franck;
Apperley, Jane;
Khoury, H. Jean;
Talpaz, Moshe;
Baccarani, Michele;
Lustgarten, Stephanie;
Haluska, Frank G.;
Guilhot, François;
Deininger, Michael W.;
Hochhaus, Andreas;
Hughes, Timothy P.;
Shah, Neil P.;
Kantarjian, Hagop M.

Publication type:

Article

Indications and Outcomes of Allogeneic Stem Cell Transplant for Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S65, doi. 10.1016/j.clml.2016.07.095

By:

Sweet, Kendra;
Emole, Josephine;
Mishra, Asmita;
Pinilla-Ibarz, Javier

Publication type:

Article

Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study.

Published in:

2016

By:

Cortes, Jorge E.;
Lipton, Jeffrey H.;
Miller, Carole B.;
Busque, Lambert;
Akard, Luke P.;
Pinilla-Ibarz, Javier;
Keir, Christopher;
Warsi, Ghulam;
Lin, Felice P.;
Mauro, Michael J.

Publication type:

journal article

Outcome of diffuse large B-cell lymphoma in the United States had improved over time but racial disaprities remain: review of SEER data.

Published in:

2011

By:

Komrokji, Rami S;
Al Ali, Najla H;
Beg, M S;
Safa, Malek M;
Rollison, Dana;
Kharfan-Dabaja, Mohamed;
Bello, Celeste;
Cultrera, Jennifer;
Sokol, Lubomir;
Pinilla-Ibarz, Javier;
Sotomayor, Eduardo M

Publication type:

Journal Article

Outcome of Diffuse Large B-Cell Lymphoma in the United States Has Improved Over Time but Racial Disparities Remain: Review of SEER Data.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 3, p. 257, doi. 10.1016/j.clml.2011.03.012

By:

Komrokji, Rami S.;
Al Ali, Najla H.;
Beg, M. S.;
Safa, Malek M.;
Rollison, Dana;
Kharfan-Dabaja, Mohamed;
Bello, Celeste;
Cultrera, Jennifer;
Sokol, Lubomir;
Pinilla-Ibarz, Javier;
Sotomayor, Eduardo M.

Publication type:

Article

Can increased immunogenicity in chronic myeloid leukemia improve outcomes?

Published in:

Expert Review of Hematology, 2019, v. 12, n. 4, p. 225, doi. 10.1080/17474086.2019.1588105

By:

Chan, Onyee;
Talati, Chetasi;
Sweet, Kendra;
Pinilla-Ibarz, Javier

Publication type:

Article

Outcomes of switching to dasatinib after imatinib-related low-grade adverse events in patients with chronic myeloid leukemia in chronic phase: the DASPERSE study.

Published in:

2018

By:

Kim, Dong-Wook;
Saussele, Susanne;
Williams, Loretta A.;
Mohamed, Hesham;
Rong, Yuanxin;
Zyczynski, Teresa;
Pinilla-Ibarz, Javier;
Abruzzese, Elisabetta

Publication type:

journal article

Assessment of Clonotypic Rearrangements and Minimal Residual Disease in Lymphoid Malignancies: A Large Cancer Center Experience Using clonoSEQ.

Published in:

Archives of Pathology & Laboratory Medicine, 2022, v. 146, n. 4, p. 485, doi. 10.5858/arpa.2020-0457-OA

By:

Hussaini, Mohammad O.;
Srivastava, Jaya;
Lik Wee Lee;
Taiga Nishihori;
Shah, Bijal D.;
Alsina, Melissa;
Pinilla-Ibarz, Javier;
Shain, Kenneth H.

Publication type:

Article

The "Hit Hard and Hit Early" Approach to the Treatment of Chronic Myeloid Leukemia: Implications of the Updated National Comprehensive Cancer Network Clinical Practice Guidelines for Routine Practice.

Published in:

Clinical Advances in Hematology & Oncology, 2013, v. 11, n. 7, p. 421

By:

Akard, Luke P.;
Albitar, Maher;
Hill, Charles E.;
Pinilla-Ibarz, Javier

Publication type:

Article

Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemia.

Published in:

International Journal of Hematology, 2014, v. 100, n. 6, p. 567, doi. 10.1007/s12185-014-1685-9

By:

Sweet, Kendra;
Al Ali, Najla;
Dalia, Samir;
Komrokji, Rami;
Crescentini, Robert;
Tinsley, Sara;
Lancet, Jeffrey;
Papenhausen, Peter;
Zhang, Ling;
Pinilla-Ibarz, Javier

Publication type:

Article

Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.

Published in:

2017

By:

Nicolini, Franck E.;
Basak, Grzegorz W.;
Kim, Dong‐Wook;
Olavarria, Eduardo;
Pinilla‐Ibarz, Javier;
Apperley, Jane F.;
Hughes, Timothy;
Niederwieser, Dietger;
Mauro, Michael J.;
Chuah, Charles;
Hochhaus, Andreas;
Martinelli, Giovanni;
DerSarkissian, Maral;
Duh, Mei Sheng;
McGarry, Lisa J.;
Kantarjian, Hagop M.;
Cortes, Jorge E.

Publication type:

journal article

Melanoma and CLL co-occurrence and survival: role of KC history.

Published in:

BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11573-z

By:

Zhao, Yayi;
Amorrortu, Rossybelle P.;
Stewart, Sandra C.;
Ghia, Kavita M.;
Williams, Vonetta L.;
Sondak, Vernon K.;
Tsai, Kenneth Y.;
Pinilla-Ibarz, Javier;
Chavez, Julio C.;
Rollison, Dana E.

Publication type:

Article

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel.

Published in:

Cancer Medicine, 2021, v. 10, n. 6, p. 1936, doi. 10.1002/cam4.3664

By:

Hoogland, Aasha I.;
Jayani, Reena V.;
Collier, Aaron;
Irizarry‐Arroyo, Nathaly;
Rodriguez, Yvelise;
Jain, Michael D.;
Booth‐Jones, Margaret;
Hyland, Kelly A.;
James, Brian W.;
Barata, Anna;
Bachmeier, Christina A.;
Chavez, Julio C.;
Khimani, Farhad;
Krivenko, Gabriel S.;
Lazaryan, Aleksandr;
Liu, Hien D.;
Nishihori, Taiga;
Pinilla‐Ibarz, Javier;
Shah, Bijal D.;
Abidi, Muneer

Publication type:

Article

Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells.

Published in:

2019

By:

Knox, Tessa;
Sahakian, Eva;
Banik, Debarati;
Hadley, Melissa;
Palmer, Erica;
Noonepalle, Satish;
Kim, Jennifer;
Powers, John;
Gracia-Hernandez, Maria;
Oliveira, Vasco;
Cheng, Fengdong;
Chen, Jie;
Barinka, Cyril;
Pinilla-Ibarz, Javier;
Lee, Norman H.;
Kozikowski, Alan;
Villagra, Alejandro

Publication type:

Correction Notice

Clinical advances in the management of chronic myelogenous leukemia: focus on bosutinib and patient considerations.

Published in:

Patient Preference & Adherence, 2014, v. 8, p. 981, doi. 10.2147/PPA.S53160

By:

Sweet, Kendra;
Pinilla-Ibarz, Javier;
Ling Zhang

Publication type:

Article

Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib.

Published in:

Biologics: Targets & Therapy, 2016, v. 10, p. 23, doi. 10.2147/BTT.S67844

By:

Emole, Josephine;
Talabi, Taiwo;
Pinilla-Ibarz, Javier

Publication type:

Article

Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse.

Published in:

European Journal of Haematology, 2022, v. 108, n. 5, p. 379, doi. 10.1111/ejh.13744

By:

Hu, Rachel;
Wei, Wei;
Mian, Agrima;
Gonter‐Aubin, Kristen;
Kabel, Charlene;
Mato, Anthony;
Stephens, Deborah M.;
Hanlon, Ashley;
Khajavian, Sirin;
Shadman, Mazyar;
Brander, Danielle;
Madanat, Yazan;
Park, Jae H.;
Tallman, Martin;
Pinilla‐Ibarz, Javier;
Hill, Brian T.

Publication type:

Article

Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML.

Published in:

Annals of Hematology, 2024, v. 103, n. 6, p. 1941, doi. 10.1007/s00277-024-05760-6

By:

Jain, Akriti G;
Gesiotto, Quinto;
Ball, Somedeb;
Nodzon, Lisa;
Rodriguez, Amanda;
Chan, Onyee;
Padron, Eric;
Kuykendall, Andrew;
Komrokji, Rami;
Sallman, David A.;
Lancet, Jeffrey E;
Pinilla-Ibarz, Javier;
Sweet, Kendra

Publication type:

Article

Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database.

Published in:

Annals of Hematology, 2023, v. 102, n. 4, p. 889, doi. 10.1007/s00277-023-05133-5

By:

Ammad Ud Din, Mohammad;
Mahmud, Amir;
Mostafa, Mariam;
Shahzad, Moazzam;
Liaqat, Hania;
Pinilla-Ibarz, Javier;
Jaglal, Michael

Publication type:

Article

Estimated Savings After Stopping Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myeloid Leukemia.

Published in:

JAMA Network Open, 2023, v. 6, n. 12, p. e2347950, doi. 10.1001/jamanetworkopen.2023.47950

By:

Winn, Aaron N.;
Atallah, Ehab;
Cortes, Jorge;
Deininger, Michael W. N.;
Kota, Vamsi;
Larson, Richard A.;
Moore, Joseph O.;
Mauro, Michael J.;
Oehler, Vivian G.;
Pinilla-Ibarz, Javier;
Radich, Jerald P.;
Shah, Neil P.;
Thompson, James E.;
Flynn, Kathryn E.

Publication type:

Article